Cargando…
Facing the challenge of viral mutations in the age of pandemic: Developing highly potent, broad‐spectrum, and safe COVID‐19 vaccines and therapeutics
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803365/ https://www.ncbi.nlm.nih.gov/pubmed/33463059 http://dx.doi.org/10.1002/ctm2.284 |
| _version_ | 1783635922765479936 |
|---|---|
| author | Su, Shan Wang, Qian Jiang, Shibo |
| author_facet | Su, Shan Wang, Qian Jiang, Shibo |
| author_sort | Su, Shan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7803365 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78033652021-01-19 Facing the challenge of viral mutations in the age of pandemic: Developing highly potent, broad‐spectrum, and safe COVID‐19 vaccines and therapeutics Su, Shan Wang, Qian Jiang, Shibo Clin Transl Med Commentary John Wiley and Sons Inc. 2021-01-12 /pmc/articles/PMC7803365/ /pubmed/33463059 http://dx.doi.org/10.1002/ctm2.284 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Commentary Su, Shan Wang, Qian Jiang, Shibo Facing the challenge of viral mutations in the age of pandemic: Developing highly potent, broad‐spectrum, and safe COVID‐19 vaccines and therapeutics |
| title | Facing the challenge of viral mutations in the age of pandemic: Developing highly potent, broad‐spectrum, and safe COVID‐19 vaccines and therapeutics |
| title_full | Facing the challenge of viral mutations in the age of pandemic: Developing highly potent, broad‐spectrum, and safe COVID‐19 vaccines and therapeutics |
| title_fullStr | Facing the challenge of viral mutations in the age of pandemic: Developing highly potent, broad‐spectrum, and safe COVID‐19 vaccines and therapeutics |
| title_full_unstemmed | Facing the challenge of viral mutations in the age of pandemic: Developing highly potent, broad‐spectrum, and safe COVID‐19 vaccines and therapeutics |
| title_short | Facing the challenge of viral mutations in the age of pandemic: Developing highly potent, broad‐spectrum, and safe COVID‐19 vaccines and therapeutics |
| title_sort | facing the challenge of viral mutations in the age of pandemic: developing highly potent, broad‐spectrum, and safe covid‐19 vaccines and therapeutics |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803365/ https://www.ncbi.nlm.nih.gov/pubmed/33463059 http://dx.doi.org/10.1002/ctm2.284 |
| work_keys_str_mv | AT sushan facingthechallengeofviralmutationsintheageofpandemicdevelopinghighlypotentbroadspectrumandsafecovid19vaccinesandtherapeutics AT wangqian facingthechallengeofviralmutationsintheageofpandemicdevelopinghighlypotentbroadspectrumandsafecovid19vaccinesandtherapeutics AT jiangshibo facingthechallengeofviralmutationsintheageofpandemicdevelopinghighlypotentbroadspectrumandsafecovid19vaccinesandtherapeutics |